IL153678A0 - A pharmaceutical component comprising a human parathyroid hormone - Google Patents

A pharmaceutical component comprising a human parathyroid hormone

Info

Publication number
IL153678A0
IL153678A0 IL15367801A IL15367801A IL153678A0 IL 153678 A0 IL153678 A0 IL 153678A0 IL 15367801 A IL15367801 A IL 15367801A IL 15367801 A IL15367801 A IL 15367801A IL 153678 A0 IL153678 A0 IL 153678A0
Authority
IL
Israel
Prior art keywords
parathyroid hormone
pharmaceutical component
human parathyroid
human
pharmaceutical
Prior art date
Application number
IL15367801A
Other languages
English (en)
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of IL153678A0 publication Critical patent/IL153678A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IL15367801A 2000-06-30 2001-06-29 A pharmaceutical component comprising a human parathyroid hormone IL153678A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000237717 2000-06-30
JP2000237718 2000-06-30
PCT/JP2001/005674 WO2002002136A1 (fr) 2000-06-30 2001-06-29 Constituants medicinaux comportant de l'hormone parathyroidienne humaine et compositions medicinales pour l'administration nasale contenant lesdits constituants

Publications (1)

Publication Number Publication Date
IL153678A0 true IL153678A0 (en) 2003-07-06

Family

ID=26597441

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15367801A IL153678A0 (en) 2000-06-30 2001-06-29 A pharmaceutical component comprising a human parathyroid hormone

Country Status (16)

Country Link
US (1) US7087248B2 (xx)
EP (1) EP1297842A4 (xx)
KR (1) KR20030016315A (xx)
CN (1) CN100518819C (xx)
AR (1) AR032461A1 (xx)
AU (2) AU6788701A (xx)
BR (1) BR0112381A (xx)
CA (1) CA2414966A1 (xx)
IL (1) IL153678A0 (xx)
MX (1) MXPA02012947A (xx)
MY (1) MY136546A (xx)
NO (1) NO325831B1 (xx)
NZ (1) NZ523457A (xx)
RU (1) RU2292219C2 (xx)
TW (1) TWI293563B (xx)
WO (1) WO2002002136A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1598074B1 (en) * 2003-02-28 2019-01-02 Chugai Seiyaku Kabushiki Kaisha Stabilized protein-containing formulations
WO2006006674A1 (ja) * 2004-07-14 2006-01-19 Chugai Seiyaku Kabushiki Kaisha Pthを含有する経粘膜投与剤
WO2007059470A2 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
EP1961765A1 (en) * 2006-12-08 2008-08-27 Zealand Pharma A/S Truncated PTH peptides with a cyclic conformation
KR200449313Y1 (ko) * 2008-02-18 2010-06-30 손복만 동파방지용 배수밸브를 구비한 가통
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
ES2843649T3 (es) 2009-09-09 2021-07-20 Asahi Kasei Pharma Corp Agente terapéutico/profiláctico que contiene PTH para la osteoporosis, caracterizado porque la PTH se administra una vez por semana en una dosis unitaria de 200 unidades
JP5969763B2 (ja) 2009-11-18 2016-08-17 旭化成ファーマ株式会社 ヒト変形性膝関節症の予防剤および／または治療剤および／または増悪抑制剤
JP2013512688A (ja) 2009-12-07 2013-04-18 ミシガン テクノロジカル ユニバーシティ クロクマの副甲状腺ホルモン及びクロクマの副甲状腺ホルモンを使用する方法
EP2471554A1 (en) 2010-12-28 2012-07-04 Hexal AG Pharmaceutical formulation comprising a biopharmaceutical drug
CN103561757B (zh) * 2011-06-07 2016-01-06 旭化成制药株式会社 高纯度含pth冷冻干燥制剂及其制造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086196A (en) * 1975-03-28 1978-04-25 Armour Pharmaceutical Company Parathyroid hormone
JP2505812B2 (ja) 1987-07-10 1996-06-12 旭化成工業株式会社 ｈ―ＰＴＨ（１―３４）凍結乾燥組成物
GB9020544D0 (en) 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
US5208041A (en) * 1991-05-23 1993-05-04 Allelix Biopharmaceuticals Inc. Essentially pure human parathyroid hormone
JPH05271279A (ja) * 1991-08-07 1993-10-19 Takeda Chem Ind Ltd ヒト副甲状腺ホルモンムテインおよびその製造法
US5977070A (en) * 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
DE19538687A1 (de) 1995-10-17 1997-04-24 Boehringer Mannheim Gmbh Stabile pharmazeutische Darreichungsformen enthaltend Parathormon

Also Published As

Publication number Publication date
NZ523457A (en) 2004-11-26
CN1440294A (zh) 2003-09-03
US20050107292A1 (en) 2005-05-19
CA2414966A1 (en) 2002-01-10
NO325831B1 (no) 2008-07-28
KR20030016315A (ko) 2003-02-26
EP1297842A1 (en) 2003-04-02
EP1297842A4 (en) 2005-03-30
NO20026055L (no) 2003-02-24
US7087248B2 (en) 2006-08-08
BR0112381A (pt) 2003-05-06
AU6788701A (en) 2002-01-14
TWI293563B (en) 2008-02-21
NO20026055D0 (no) 2002-12-17
AR032461A1 (es) 2003-11-12
WO2002002136A1 (fr) 2002-01-10
MXPA02012947A (es) 2003-05-15
CN100518819C (zh) 2009-07-29
MY136546A (en) 2008-10-31
AU2001267887B2 (en) 2007-02-15
RU2292219C2 (ru) 2007-01-27

Similar Documents

Publication Publication Date Title
AU2753001A (en) A medicinal aerosol formulation
EP1296723A4 (en) DRUG PREPARATION FOR AEROSOL
AU4519001A (en) A medicinal aerosol formulation
AU1846702A (en) Anti-proliferative drugs
IL154012A0 (en) Hydrogel-driven drug dosage form
GB0026647D0 (en) Medicament dispenser
GB0025092D0 (en) Medicament dispenser
IL153678A0 (en) A pharmaceutical component comprising a human parathyroid hormone
GB0031176D0 (en) Medicament dispenser
HUP0303860A3 (en) A pharmaceutical tablet having a high active ingredient
AU2623401A (en) A medicinal aerosol formulation
HUP0600143A2 (en) A stable pharmaceutical formulation comprising torsemide modification ii
IL147731A0 (en) Peptide pharmaceutical formulations
AU5654701A (en) Drug delivery mask
EP1292283A4 (en) MEDICAL AEROSOL FORMULATION
GB2361643B (en) Delivery capsules
GB0021487D0 (en) Pharmaceutical
GB0013400D0 (en) A formulation
EP1414417A4 (en) PHARMACEUTICAL FORMULATION
ZA99349B (en) A pharmaceutical formulation.
GB0020538D0 (en) Medicament dispenser
IL156192A0 (en) Anti-proliferative drugs
GB0028565D0 (en) Pharmaceutical use
GB0028153D0 (en) A syringe
GB0030650D0 (en) A syringe